A stabilised GHRH analogue. The only compound on this list FDA-approved for a body-composition indication.
Meaningful reductions in visceral abdominal fat; modest gains in lean muscle area/density; smaller waist circumference; improved body composition.
Approved as Egrifta SV at 1.4 mg once daily and Egrifta WR at 1.28 mg once daily, for reduction of excess visceral abdominal fat in HIV-associated lipodystrophy - a specific patient population, not general fat loss. The two formulations are not substitutable. The application became a BLA in March 2020, which means tesamorelin cannot lawfully be compounded. Both Canadian DINs are cancelled, so there is no authorised Canadian product as of September 2026.
No reference figure is given here. There is no personal reference on file for this compound, and we would rather leave it blank than fill it with a guess. The Tesamorelin calculator will do the arithmetic for any amount you enter.
| Tesamorelin | 1 mL water | 2 mL water | 3 mL water | 5 mL water |
|---|---|---|---|---|
| 10 mg vial | 10,000 mcg/mL | 5,000 mcg/mL | 3,333 mcg/mL | 2,000 mcg/mL |
| One unit (0.01 mL) | 100 mcg | 50 mcg | 33 mcg | 20 mcg |
Concentration = vial contents ÷ water added. It is the same compound at every volume — more water only means a weaker solution, larger syringe marks that are easier to read, and a larger injection volume. On a standard U-100 insulin syringe, one unit is 0.01 mL at any barrel size.
Education only. This page is educational. Most compounds referenced are not approved for human use, and a "research use only" label carries no legal status of its own.
Reported, not established. Any figure shown is a reported personal reference at the reconstitution stated — not a community average, not a clinical dose, and not necessarily right for anyone else's body, goals, or product.
Blank is deliberate. Where no figure appears, there is no personal reference to give. We would rather say nothing than imply confidence that isn't there.
Not medical advice. Nothing here constitutes medical advice, diagnosis, or treatment. Several of these are prescription medicines in Canada and the US, and several are approved nowhere at all. Consult a qualified healthcare professional before beginning any protocol.